Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2009 2
2010 3
2011 3
2012 1
2013 2
2014 1
2015 4
2016 5
2017 2
2018 4
2019 6
2020 5
2021 3
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune pre-disease.
Bieber K, Hundt JE, Yu X, Ehlers M, Petersen F, Karsten CM, Köhl J, Kridin K, Kalies K, Kasprick A, Goletz S, Humrich JY, Manz RA, Künstner A, Hammers CM, Akbarzadeh R, Busch H, Sadik CD, Lange T, Grasshoff H, Hackel AM, Erdmann J, König I, Raasch W, Becker M, Kerstein-Stähle A, Lamprecht P, Riemekasten G, Schmidt E, Ludwig RJ. Bieber K, et al. Among authors: humrich jy. Autoimmun Rev. 2023 Feb;22(2):103236. doi: 10.1016/j.autrev.2022.103236. Epub 2022 Nov 24. Autoimmun Rev. 2023. PMID: 36436750 Review.
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
Graßhoff H, Comdühr S, Monne LR, Müller A, Lamprecht P, Riemekasten G, Humrich JY. Graßhoff H, et al. Among authors: humrich jy. Front Immunol. 2021 Apr 1;12:648408. doi: 10.3389/fimmu.2021.648408. eCollection 2021. Front Immunol. 2021. PMID: 33868284 Free PMC article. Review.
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial.
Humrich JY, Cacoub P, Rosenzwajg M, Pitoiset F, Pham HP, Guidoux J, Leroux D, Vazquez T, Riemekasten G, Smolen JS, Tsokos G, Klatzmann D. Humrich JY, et al. Ann Rheum Dis. 2022 Dec;81(12):1685-1694. doi: 10.1136/ard-2022-222501. Epub 2022 Aug 16. Ann Rheum Dis. 2022. PMID: 35973803 Clinical Trial.
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L, Aherrahrou R, Reinberger T, Schulz A, Ten Cate V, Robles AP, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner KJ, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska JH, Riemekasten G, Wild PS. Müller FS, et al. Among authors: humrich jy. Eur Heart J. 2023 Dec 14;44(47):4935-4949. doi: 10.1093/eurheartj/ehad666. Eur Heart J. 2023. PMID: 37941454 Free PMC article.
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Plaça DR, Fonseca DLM, Humrich JY, Müller A, Giil LM, Graßhoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y. Cabral-Marques O, et al. Among authors: humrich jy. Nat Commun. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5. Nat Commun. 2022. PMID: 35264564 Free PMC article.
Phenotyping of Adaptive Immune Responses in Inflammatory Diseases.
Humrich JY, Bernardes JP, Ludwig RJ, Klatzmann D, Scheffold A. Humrich JY, et al. Front Immunol. 2020 Nov 25;11:604464. doi: 10.3389/fimmu.2020.604464. eCollection 2020. Front Immunol. 2020. PMID: 33324421 Free PMC article. Review.
Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.
Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, Ehlers M, Epplen JT, Holl-Ulrich K, Wiech T, Kalies K, Lange T, Laudien M, Laskay T, Gemoll T, Schumacher U, Ullrich S, Busch H, Ibrahim S, Fischer N, Hasselbacher K, Pries R, Petersen F, Weppner G, Manz R, Humrich JY, Nieberding R, Riemekasten G, Müller A. Lamprecht P, et al. Among authors: humrich jy. Front Immunol. 2018 Apr 9;9:680. doi: 10.3389/fimmu.2018.00680. eCollection 2018. Front Immunol. 2018. PMID: 29686675 Free PMC article. Review.
46 results